You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (15)

Journals (0)

1-10 of 15 results for hypomethylating agent (HMA)

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Open access

Research article

First published 2026

Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Amer M. Zeidan, Ruizhi Zhao, Jon G. Tepsick [...]

Therapeutic Advances in Hematology

Select article: Emerging treatment options for patients with high-risk myelodysplastic syndrome

Open access

Review article

First published 2020

Emerging treatment options for patients with high-risk myelodysplastic syndrome

Jan Philipp Bewersdorf, Hetty Carraway, Thomas Prebet

Therapeutic Advances in Hematology

Select article: Management of myelodysplastic syndromes after failure of response to hypomethylating agents

Open access

Review article

First published 2019

Management of myelodysplastic syndromes after failure of response to hypomethylating agents

Angela Gil-Perez, Guillermo Montalban-Bravo

Therapeutic Advances in Hematology

Select article: The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Open access

Review article

First published 2022

The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Anson Snow, Joshua F. Zeidner

Therapeutic Advances in Hematology

Select article: Clinical activity,pharmacokinetics,and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review

Open access

Review article

First published 2024

Clinical activity,pharmacokinetics,and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review

Ryan Haumschild, Julie Kennerly-Shah, Lisa Barbarotta [...]

Journal of Oncology Pharmacy Practice

Select article: Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents

Open access

Research article

First published 2020

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents

Ka-Won Kang, Byung-Hyun Lee, Min Ji Jeon [...]

Therapeutic Advances in Hematology

Select article: Venetoclax-containing regimens in acute myeloid leukemia

Open access

Review article

First published 2021

Venetoclax-containing regimens in acute myeloid leukemia

Ibrahim Aldoss, Vinod Pullarkat, Anthony S. Stein

Therapeutic Advances in Hematology

Select article: Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy

Open access

Review article

First published 2019

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy

Guillaume Richard-Carpentier, Courtney D. DiNardo

Therapeutic Advances in Hematology

Select article: Adding venetoclax or hypomethylating agents to induction chemotherapy as first-line treatment for adults with acute myeloid leukemia: a retrospective case-cohort study

Open access

Research article

First published 2024

Adding venetoclax or hypomethylating agents to induction chemotherapy as first-line treatment for adults with acute myeloid leukemia: a retrospective case-cohort study

Fangfei Xu, Kuangguo Zhou, Duanhao Gong [...]

Therapeutic Advances in Hematology

Select article: Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

Retricted access

Review article

First published 2022-4

Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

Clement Chung

Annals of Pharmacotherapy

1
2
10 / page

Article type

Publication date

Subjects

Access